Comparative Pharmacology
Head-to-head clinical analysis: BARSTATIN 100 versus SIMVASTATIN.
Head-to-head clinical analysis: BARSTATIN 100 versus SIMVASTATIN.
BARSTATIN 100 vs SIMVASTATIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
HMG-CoA reductase inhibitor; decreases cholesterol synthesis in the liver by competitively inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, leading to upregulated LDL receptor expression and enhanced clearance of LDL from the bloodstream.
Competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Reduces hepatic cholesterol synthesis, increases LDL receptor expression, and lowers plasma LDL cholesterol.
100 mg orally once daily.
10-40 mg orally once daily in the evening; maximum 80 mg/day.
None Documented
None Documented
Terminal elimination half-life: 3-4 hours; in renal impairment (CrCl <30 mL/min) extended to 8-12 hours; clinical context: supports twice-daily dosing in normal renal function
Clinical Note
moderateSimvastatin + Levofloxacin
"The serum concentration of Levofloxacin can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Norfloxacin
"The serum concentration of Norfloxacin can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Prednisolone
"The serum concentration of Prednisolone can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Resveratrol
The terminal elimination half-life of simvastatin is approximately 2-3 hours, but for the active metabolite (simvastatin acid) it is about 1.9 hours; clinical lipid-lowering effects persist longer due to sustained HMG-CoA reductase inhibition.
Renal: 70% unchanged; biliary/fecal: 30% as metabolites
Primarily hepatic metabolism, with approximately 13% excreted in urine as metabolites and 60% in feces via biliary elimination; less than 0.5% of the active form is excreted unchanged in urine.
Category C
Category D/X
Statin
Statin
"The serum concentration of Resveratrol can be increased when it is combined with Simvastatin."